What factors influence immunoassay cross-reactivity and false positives?

What factors influence immunoassay cross-reactivity and false positives?

• A. Temperature of the reaction.
• B. Sample volume.
• C. Structural similarity among compounds, over-the-counter medications, and metabolites that resemble the target analyte.
• D. Instrument brand.

Answer: (C)

Cross-reactivity in immunoassays happens when the antibody designed to bind a specific target also binds other compounds that look similar enough to fit the same binding site. The key idea is structural similarity: substances that resemble the target analyte—such as other drugs, their metabolites, or common over-the-counter medications—can mimic the target’s epitopes and trigger a binding event. When these similar compounds bind, they generate a signal as if the target were present, leading to a false positive. The extent of this cross-binding depends on how closely the chemical structure and functional groups of the interfering compounds match the epitope recognized by the antibody and how permissive the antibody binding is to similar shapes. Temperature, sample volume, and instrument brand may affect overall assay performance or signal strength, but they do not establish cross-reactivity themselves. The root cause of false positives in this context is the antibody’s recognition of structurally similar compounds, not these other factors.

Cross-reactivity in immunoassays happens when the antibody designed to bind a specific target also binds other compounds that look similar enough to fit the same binding site. The key idea is structural similarity: substances that resemble the target analyte—such as other drugs, their metabolites, or common over-the-counter medications—can mimic the target’s epitopes and trigger a binding event. When these similar compounds bind, they generate a signal as if the target were present, leading to a false positive. The extent of this cross-binding depends on how closely the chemical structure and functional groups of the interfering compounds match the epitope recognized by the antibody and how permissive the antibody binding is to similar shapes.

Temperature, sample volume, and instrument brand may affect overall assay performance or signal strength, but they do not establish cross-reactivity themselves. The root cause of false positives in this context is the antibody’s recognition of structurally similar compounds, not these other factors.